Advertisement
Screener

VERICEL CORPORATION (VCEL) Net Income

VERICEL CORPORATION Net Income

VERICEL CORPORATION (VCEL) reported Net Income of $2.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement

us-gaap:NetIncomeLoss · last filed 2026-07-30

  • VERICEL CORPORATION net income (loss) attributable to parent for the quarter ending 2026-06-30 was $2.21M.
  • VERICEL CORPORATION net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$6.30M.
  • VERICEL CORPORATION net income (loss) attributable to parent for the quarter ending 2025-12-31 was $23.24M, a 17.35% increase year-over-year.
  • VERICEL CORPORATION net income (loss) attributable to parent for the quarter ending 2025-09-30 was $5.07M.
  • VERICEL CORPORATION net income (loss) attributable to parent for fiscal 2025 was $16.52M, a 59.41% increase from fiscal 2024.
  • VERICEL CORPORATION net income (loss) attributable to parent for fiscal 2024 was $10.36M.
  • VERICEL CORPORATION net income (loss) attributable to parent for fiscal 2023 was -$3.18M.
  • VERICEL CORPORATION net income (loss) attributable to parent for fiscal 2022 was -$16.71M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 276 monthNet Income (Loss) Attributable to Parent 279 monthNet Income (Loss) Attributable to Parent 282 monthNet Income (Loss) Attributable to Parent 285 monthNet Income (Loss) Attributable to Parent 288 monthNet Income (Loss) Attributable to Parent 291 monthNet Income (Loss) Attributable to Parent 294 monthNet Income (Loss) Attributable to Parent 297 monthNet Income (Loss) Attributable to Parent 300 month
2026-06-30$2.21M
10-Q · filed 2026-07-30
-$4.10M
10-Q · filed 2026-07-30
$19.15M
derived: sum of 3 quarters · filed 2026-07-30
$24.22M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$6.30M
10-Q · filed 2026-07-30
$16.94M
derived: sum of 2 quarters · filed 2026-07-30
$22.02M
derived: sum of 3 quarters · filed 2026-07-30
$21.46M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$23.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$28.32M
derived: sum of 2 quarters · filed 2026-02-26
$27.76M
derived: sum of 3 quarters · filed 2026-07-30
$16.52M
10-K · filed 2026-02-26
2025-09-30$5.07M
10-Q · filed 2025-11-06
$4.52M
derived: sum of 2 quarters · filed 2026-07-30
-$6.72M
10-Q · filed 2025-11-06
$13.08M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$553.00K
10-Q · filed 2026-07-30
-$11.80M
10-Q · filed 2026-07-30
$8.01M
derived: sum of 3 quarters · filed 2026-07-30
$7.11M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$11.25M
10-Q · filed 2026-07-30
$8.56M
derived: sum of 2 quarters · filed 2026-07-30
$7.66M
derived: sum of 3 quarters · filed 2026-07-30
$2.98M
derived: sum of 4 quarters · filed 2026-07-30
2024-12-31$19.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$18.91M
derived: sum of 2 quarters · filed 2026-02-26
$14.22M
derived: sum of 3 quarters · filed 2026-02-26
$10.36M
10-K · filed 2026-02-26
2024-09-30-$901.00K
10-Q · filed 2025-11-06
-$5.58M
derived: sum of 2 quarters · filed 2025-11-06
-$9.45M
10-Q · filed 2025-11-06
$3.55M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$4.68M
10-Q · filed 2025-11-06
-$8.54M
10-Q · filed 2025-07-31
$4.45M
derived: sum of 3 quarters · filed 2026-02-26
$789.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$3.86M
10-Q · filed 2025-11-06
$9.13M
derived: sum of 2 quarters · filed 2026-02-26
$5.47M
derived: sum of 3 quarters · filed 2026-02-26
$451.00K
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$12.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$9.33M
derived: sum of 2 quarters · filed 2026-02-26
$4.31M
derived: sum of 3 quarters · filed 2026-02-26
-$3.18M
10-K · filed 2026-02-26
2023-09-30-$3.66M
10-Q · filed 2024-11-07
-$8.68M
derived: sum of 2 quarters · filed 2024-11-07
-$16.18M
10-Q · filed 2024-11-07
-$10.25M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$5.02M
10-Q · filed 2024-11-07
-$12.52M
10-Q · filed 2024-08-01
-$6.59M
derived: sum of 3 quarters · filed 2025-02-27
-$13.17M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$7.50M
10-Q · filed 2024-11-07
-$1.57M
derived: sum of 2 quarters · filed 2025-02-27
-$8.15M
derived: sum of 3 quarters · filed 2025-02-27
-$17.11M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$5.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$655.00K
derived: sum of 2 quarters · filed 2025-02-27
-$9.62M
derived: sum of 3 quarters · filed 2025-02-27
-$16.71M
10-K · filed 2025-02-27
2022-09-30-$6.58M
10-Q · filed 2023-11-08
-$15.54M
derived: sum of 2 quarters · filed 2023-11-08
-$22.63M
10-Q · filed 2023-11-08
-$18.10M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$8.96M
10-Q · filed 2023-11-08
-$16.05M
10-Q · filed 2023-08-02
-$11.52M
derived: sum of 3 quarters · filed 2024-02-29
-$16.45M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$7.09M
10-Q · filed 2023-11-08
-$2.56M
derived: sum of 2 quarters · filed 2024-02-29
-$7.49M
derived: sum of 3 quarters · filed 2024-02-29
-$11.27M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$4.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$396.00K
derived: sum of 2 quarters · filed 2024-02-29
-$4.18M
derived: sum of 3 quarters · filed 2024-02-29
-$7.47M
10-K · filed 2024-02-29
2021-09-30-$4.93M
10-Q · filed 2022-11-09
-$8.72M
derived: sum of 2 quarters · filed 2022-11-09
-$12.01M
10-Q · filed 2022-11-09
$214.00K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$3.79M
10-Q · filed 2022-11-09
-$7.08M
10-Q · filed 2022-08-03
$5.14M
derived: sum of 3 quarters · filed 2022-11-09
$8.76M
derived: sum of 4 quarters · filed 2022-11-09
2021-03-31-$3.29M
10-Q · filed 2022-11-09
$8.93M
derived: sum of 2 quarters · filed 2022-11-09
$12.55M
derived: sum of 3 quarters · filed 2022-11-09
$4.28M
derived: sum of 4 quarters · filed 2022-11-09
2020-12-31$12.22M
10-K · filed 2021-02-24
$15.84M
derived: sum of 2 quarters · filed 2021-11-09
$7.57M
derived: sum of 3 quarters · filed 2021-11-09
$2.86M
10-K · filed 2023-02-23
2020-09-30$3.62M
10-Q · filed 2021-11-09
-$4.65M
derived: sum of 2 quarters · filed 2021-11-09
-$9.36M
10-Q · filed 2021-11-09
$145.00K
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$8.27M
10-Q · filed 2021-11-09
-$12.97M
10-Q · filed 2021-08-04
-$3.47M
derived: sum of 3 quarters · filed 2021-11-09
-$3.00K
derived: sum of 4 quarters · filed 2021-11-09
2020-03-31-$4.71M
10-Q · filed 2021-11-09
$4.80M
derived: sum of 2 quarters · filed 2021-11-09
$8.27M
derived: sum of 3 quarters · filed 2021-11-09
-$11.53M
derived: sum of 4 quarters · filed 2021-11-09
2019-12-31$9.50M
10-K · filed 2021-02-24
$12.97M
derived: sum of 2 quarters · filed 2021-02-24
-$6.82M
derived: sum of 3 quarters · filed 2021-02-24
-$9.66M
10-K · filed 2022-02-24
2019-09-30$3.47M
10-K · filed 2021-02-24
-$16.32M
derived: sum of 2 quarters · filed 2021-02-24
-$19.17M
10-Q · filed 2020-11-05
-$13.92M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30-$19.79M
10-K · filed 2021-02-24
-$22.64M
10-Q · filed 2020-08-05
-$17.39M
derived: sum of 3 quarters · filed 2021-02-24
-$18.46M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31-$2.84M
10-K · filed 2021-02-24
$2.40M
derived: sum of 2 quarters · filed 2021-02-24
$1.33M
derived: sum of 3 quarters · filed 2021-02-24
-$3.32M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$5.24M
10-K · filed 2020-02-25
$4.17M
derived: sum of 2 quarters · filed 2020-02-25
-$478.00K
derived: sum of 3 quarters · filed 2020-02-25
-$8.14M
10-K · filed 2021-02-24
2018-09-30-$1.07M
10-K · filed 2020-02-25
-$5.72M
derived: sum of 2 quarters · filed 2020-02-25
-$13.38M
10-Q · filed 2019-11-05
-$13.09M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$4.65M
10-K · filed 2020-02-25
-$12.31M
10-Q · filed 2019-08-06
-$12.02M
derived: sum of 3 quarters · filed 2020-02-25
-$17.43M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$7.66M
10-K · filed 2020-02-25
-$7.37M
derived: sum of 2 quarters · filed 2020-02-25
-$12.78M
derived: sum of 3 quarters · filed 2020-02-25
-$15.17M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$287.00K
10-K · filed 2018-03-05
-$5.12M
derived: sum of 2 quarters · filed 2019-02-26
-$7.51M
derived: sum of 3 quarters · filed 2019-02-26
-$17.29M
10-K · filed 2020-02-25
2017-09-30-$5.41M
10-K · filed 2019-02-26
-$7.79M
derived: sum of 2 quarters · filed 2019-02-26
-$17.57M
10-Q · filed 2018-11-06
-$17.29M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$2.39M
10-K · filed 2019-02-26
-$12.17M
10-Q · filed 2018-08-06
-$11.88M
derived: sum of 3 quarters · filed 2019-02-26
-$18.55M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$9.78M
10-K · filed 2019-02-26
-$9.49M
derived: sum of 2 quarters · filed 2019-02-26
-$16.17M
derived: sum of 3 quarters · filed 2019-02-26
-$19.21M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$287.00K
10-K · filed 2019-02-26
-$6.20M
10-K · filed 2017-03-13
-$6.39M
derived: sum of 2 quarters · filed 2019-02-26
-$9.43M
derived: sum of 3 quarters · filed 2019-02-26
-$19.57M
10-K · filed 2019-02-26
2016-09-30-$6.67M
10-K · filed 2018-03-05
-$9.72M
derived: sum of 2 quarters · filed 2018-03-05
-$13.37M
10-Q · filed 2017-11-07
-$18.28M
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30-$3.04M
10-K · filed 2018-03-05
-$6.69M
10-Q · filed 2017-08-09
-$11.60M
derived: sum of 3 quarters · filed 2018-03-05
-$16.02M
derived: sum of 4 quarters · filed 2018-03-05
2016-03-31-$3.65M
10-K · filed 2018-03-05
-$8.56M
derived: sum of 2 quarters · filed 2018-03-05
-$12.98M
derived: sum of 3 quarters · filed 2018-03-05
-$15.13M
derived: sum of 4 quarters · filed 2018-03-05
2015-12-31-$4.91M
10-K · filed 2017-03-13
-$9.33M
derived: sum of 2 quarters · filed 2017-03-13
-$11.48M
derived: sum of 3 quarters · filed 2017-03-13
-$16.34M
10-K · filed 2018-03-05
2015-09-30-$4.42M
10-K · filed 2017-03-13
-$6.57M
derived: sum of 2 quarters · filed 2017-03-13
-$11.43M
10-Q · filed 2016-11-07
-$13.80M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$2.15M
10-K · filed 2017-03-13
-$7.01M
10-Q · filed 2016-08-08
-$9.38M
derived: sum of 3 quarters · filed 2017-03-13
-$16.30M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31-$4.86M
10-K · filed 2017-03-13
-$7.23M
derived: sum of 2 quarters · filed 2017-03-13
-$14.15M
derived: sum of 3 quarters · filed 2017-03-13
-$18.79M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31-$2.37M
10-K · filed 2016-03-14
-$9.29M
derived: sum of 2 quarters · filed 2016-03-14
-$13.93M
derived: sum of 3 quarters · filed 2016-03-14
-$19.92M
10-K · filed 2017-03-13
2014-09-30-$6.92M
10-K · filed 2016-03-14
-$11.55M
derived: sum of 2 quarters · filed 2016-03-14
-$17.55M
10-Q · filed 2015-11-13
-$20.47M
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30-$4.64M
10-K · filed 2016-03-14
-$10.63M
10-Q · filed 2015-08-12
-$13.55M
derived: sum of 3 quarters · filed 2016-03-14
-$15.82M
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31-$6.00M
10-K · filed 2016-03-14
-$8.91M
derived: sum of 2 quarters · filed 2016-03-14
-$11.18M
derived: sum of 3 quarters · filed 2016-03-14
-$16.07M
derived: sum of 4 quarters · filed 2016-03-14
-$291.97M
10-Q · filed 2014-05-15
2013-12-31-$2.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
-$5.19M
derived: sum of 2 quarters · filed 2016-03-14
-$10.08M
derived: sum of 3 quarters · filed 2016-03-14
-$15.62M
10-K · filed 2016-03-14
-$285.98M
10-K · filed 2014-03-13
2013-09-30-$2.27M
10-Q · filed 2014-11-13
-$7.16M
derived: sum of 2 quarters · filed 2014-11-13
-$12.71M
10-Q · filed 2014-11-13
-$19.36M
derived: sum of 4 quarters · filed 2015-03-25
-$283.06M
10-Q · filed 2013-11-12
2013-06-30-$4.89M
10-Q · filed 2014-08-14
-$10.43M
10-Q · filed 2014-08-14
-$17.08M
derived: sum of 3 quarters · filed 2015-03-25
-$23.12M
derived: sum of 4 quarters · filed 2015-03-25
-$280.79M
10-Q · filed 2013-08-07
2013-03-31-$5.54M
10-Q · filed 2014-05-15
-$12.19M
derived: sum of 2 quarters · filed 2015-03-25
-$18.23M
derived: sum of 3 quarters · filed 2015-03-25
-$25.56M
derived: sum of 4 quarters · filed 2015-03-25
-$275.90M
10-Q · filed 2013-05-08
2012-12-31-$6.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
-$12.68M
derived: sum of 2 quarters · filed 2015-03-25
-$20.02M
derived: sum of 3 quarters · filed 2015-03-25
-$29.47M
10-K · filed 2015-03-25
-$270.35M
10-K · filed 2013-03-18
2012-09-30-$6.03M
10-Q · filed 2013-11-12
-$13.37M
derived: sum of 2 quarters · filed 2013-11-12
-$22.82M
10-Q · filed 2013-11-12
-$25.61M
derived: sum of 4 quarters · filed 2014-03-13
-$263.70M
10-Q · filed 2012-11-08
2012-06-30-$7.33M
10-Q · filed 2013-08-07
-$16.79M
10-Q · filed 2013-08-07
-$19.58M
derived: sum of 3 quarters · filed 2014-03-13
-$21.51M
derived: sum of 4 quarters · filed 2014-03-13
-$257.67M
10-Q · filed 2012-08-07
2012-03-31-$9.46M
10-Q · filed 2013-05-08
-$12.24M
derived: sum of 2 quarters · filed 2014-03-13
-$14.18M
derived: sum of 3 quarters · filed 2014-03-13
-$24.14M
derived: sum of 4 quarters · filed 2014-03-13
-$250.34M
10-Q · filed 2012-05-10
2011-12-31-$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
-$4.72M
derived: sum of 2 quarters · filed 2014-03-13
-$14.68M
derived: sum of 3 quarters · filed 2014-03-13
-$19.67M
10-K · filed 2014-03-13
2011-09-30-$1.93M
10-Q · filed 2012-11-08
-$11.89M
derived: sum of 2 quarters · filed 2012-11-08
-$16.88M
10-Q · filed 2012-11-08
2011-06-30-$9.96M
10-Q · filed 2012-08-07
-$14.95M
10-Q · filed 2012-08-07
2011-03-31-$4.99M
10-Q · filed 2012-05-10
2010-12-31-$19.09M
10-K · filed 2013-03-18
2010-06-30-$14.56M
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80